The Drug Supply Chain Security Act (DSCSA) aims to build an electronic, interoperable system to accurately trace prescription drugs throughout the supply chain as they are distributed in the United States. Its goal is to verify legitimate products, detect suspect and illegitimate products, and better facilitate drug product recalls to protect consumers from counterfeit, contaminated, or otherwise harmful products.
The FDA has outlined tiered compliance deadlines for DSCSA implemention, beginning with prescription drug manufacturers by November 27, 2017. Repackagers must reach compliance by November 27, 2018, followed by wholesale distributors by November 27, 2019, and dispensers by November 27, 2020.
DSCSA requires a unique product identifier at the prescription drug package level that consists of:
We’re here to help. Please tell us a little more about your company and we will be in touch to discuss your pharmaceutical labeling needs.
© Copyright 2020 Teklynx Newco SAS. All Rights Reserved.